Oncology & Hematology Medical Oncology Therapeutic Experts and Consultants

Nous contacter

The dedicated clinical oncology team—led by Dr. Isagani Chico, vice president and global therapeutic head of oncology—has over 50 oncology physicians with an average of 23 years of industry and clinical experience globally across Europe, North America, Latin America and Asia. Our medical team’s clinical, academic and industry experience covers the majority of oncology indications, including pediatric oncology; and our combined therapeutic area experience extends from translational/early-phase development through product launch and late-phase/postmarketing studies.

Our team of medical experts/consultants also have specialized training or certification in specialized areas of oncology clinical development (see below) and understand the global treatment and competitive landscape, major trends in healthcare and clinical management workflow in these areas. As such, we can provide consultation services in life-cycle management of specific indications including:

  • Clinical development planning
  • Establishment of target product profiles
  • Feasibility, risk assessment and execution
  • Registries
  • Program-level medical oversight

Our physicians with prior experience in these areas of clinical development can also provide study-level oversight, working hand in hand with our experts.    


Meet Our Teams of Oncology Experts and Consultants

 

Click on a specific area of interest, or scroll down to view the broader oncology teams.

Cancer Type

Subject Matter Expert

 

 

   Medically Experienced
Breast and Gyne Kamal Saini
Laura Vidal (Gyn)
Liang Wan (breast Cancer)
Carolina Dutra
Chia Portera
Zarah Lucas
Luca Cantini
Valery Novikov
Olga Bodriagova
Konstantin Haradinov
Anna Sowa
Diana Aguirre
Marcin Koziej (Breast Cancer)
Lingjuan Pang
Qing Gong
Reigetsu Yoshikawa
Kazuya Iwamoto
Krane Huang
Thoracic Malignancies Carolina Dutra
Jose Daniel Fanjul Fuente
Zarah Lucas
Valery Chatikine
Marco Durini
Idoko Salifu
Valery Novikov
Zehra Pamuklar
Diana Aguirre
Maksym Novikov
Anna Sowa
Irina Savina
Krane Huang
Jingium Huang
Suning Qian
Chunyan Li
Kazuya Iwamoto
Jinju Kim (Lung)
Luca Cantini
Tête et cou Laura Vidal
Zarah Lucas
Begona de las Heras
Zehra Pamuklar
Carolina Dutra
Lingjuan Pang
Reigetsu Yoshikawa
Mélanome Marco Durini
Brian Hamilton
Zarah Lucas
Ewa Hajek
Victor Angelico
Irina Savina
Stefanella Bortini
Zehra Pamukla
Pediatric Oncology Carlo Lanza
Geoff Kannan (+ Ped Neuro-oncology)
Nazia Iqba
Chiara Chiruzzi (CNS pediatric and solid)
Pediatric Hematology Carlo Lanza
Geoff Kannan
Nazia Iqbal
 
SNC Geoff Kannan
Carolina Dutra
Begona de las Heras
Laura Vidal
Reigetsu Yoshikawa
GI Ariel Aguilo
Reigetsu Yoshikawa
Kazuya Iwamoto
Huang Krane
Irina Savina (CRC, biliary)
Kostantin Haradinov (CRC, gastric, HCC and Pancreas)
Valery Navikov (Neuroendocrine)
Maksym Novikov (CRC, HCC, Pancreas, Gastric)
Irina Savina (CRC)
Victor Angelico
Liliana Baila (HCC)
Diana Aguirre (CRC)
Zehra Pamuklar
Chia Portera (Pancreatic)
Lucas Zarah
Lingjuan Pang
Liang Wan
Krane Huang
Jingium Huang (Pancreas & Colorectal; Liver Tumors)
GU Howard Yeh
Franklyn Gaylis
Valery Novikov (renal)
Jose Espinoza (bladder)
Valery Chatikine
Jose Daniel Fanjul (Kidney)
Marcin Koziej (Bladder Ca)
Oxana Bzhadug (prostate)
Laura Vidal (Bladder)
Lingjuan Pang
Kazuya Iwamoto (Prostate)
Liang Wan
Chunyan Li (Prostate)
Suning Qian (Prostate)
Reigetsu Yoshikawa (Prostate)
Lucas Zarah
Malignant Hematology Martine Poelman
Carlo Lanza
Carmen Besliu (hemophilia)
Espinoza Jose
Victor Angelico (Lymphoma)
Maria Berraondo
Maria Elvira Parellada
Yin Liu
Valery Chatikine
Patricia Brandalis
Kamal Saini
Valery Novikov (Lymphoma)
Carmen Beslliu (myelofibrosis, polycythemia vera)
Liliana Baila
Victor Angelico (Lymphoma)
Howard Yeh (Myeloma)
Brian Hamilton
Idoko Salifu
Lucas Zarah
Qing Gong
Xiaoling Li
Kazuya Iwamoto (Leukemia, Lymphoma)
Liang Wan (Lymphoma)
Yi Pi
Suning Qian (Lymphoma; Myeloma)
Chunyan Li
CGT Brian Hamilton
Carlo Lanza
Jose Espinoza
Carmen Besliu
Victor Angelico
Maria Elvira Parellada
Carolina Dutra
Suning Qian
Reigetsu Yoshikawa
Nazia Iqbal
Oncolytic Viruses Laura Vidal
Begona de las Heras
Brian Hamilton
Oxana Bzhadug
Early Phase Solid Tumors Begona de las Heras
Laura Vidal
Brian Hamilton
Ariel Aguilo
Paolo Nunes
Chia Portera
Zehra Pamuklar
Geoff Kannan
Marco Durini
Victor Angelico
Chiara Chiruzzi
Olga Bodriagova
Jose Daniel Fanjul
Valery Novikov
Stefanella Bortini
Jose Espinoza
Lingjuan Pang
Qing Gong
Reigetsu Yoshikawa
Kazuya Iwamoto
Liang Wan
Vaccins Brian Hamilton Olga Bodriagova
Stefanella Bortini
Laura Vidal
Begona de las Heras
Reigetsu Yoshikawa
Sarcome   Stefanella Bortini
Reigetsu Yoshikawa
Brian Hamilton
Carolina Dutra
Supportive Care   Laura Vidal
Chia Portera
Maria Berraondo
Jose Espinoza
Radiopharmaceuticals Liliana Baila
Laura Vidal
Stefanella Bortini
Chiara Chiruzzi (radiotherapist)
Irina Savina
Geoffrey Kannan
ECD Ariel Aguilo
Begona de las Heras
Kamal Saini
Laura Vidal
Precision Oncology/Diagnostics Kamal Saini
Begona de las Heras
Maria Elvira Parellada
Begona de las Heras
Ariel Aguilo
Phase IV/marketing Marco Durini
Moez Benali
Laura Vidal

Medical Science Leadership Committee (MSLC)

 

Priority Business Area

MSLC Leader

 

Subject Matter Experts
Decetralized Clinical Trials (DCT) Ariel Aguilo Begona de las Heras
Kamal Saini
Laura Vidal
Diana Aguirre Coda-Forno
Médecine de précision Kamal Veer Saini Begona de las Heras
Maria Elvira Parellada
Early Phase/ Hybrid/Innovative Trial Designs Oncology Begona de las Heras Paulo Nunes
Laura Vidal
Brian Hamilton
Ariel Aguilo
Carlo Lanza
Medical Services Program Leadershipand Clinical Data Excellence Laura Vidal Martine Poelman
Ariel Aguilo
Marco Durini
Cell and Gene Therapy (CGT) Brian Hamilton Carlo Lanza
Jose Espinoza
Carmen Besliu

Subject Matter Expert (SME) definition:

A subject-matter expert in Oncology is someone with board certification/specialization, training, knowledge, and medical and clinical trials experience in a particular indication, drug class or area of oncology clinical research. This person has a thorough understanding of the global treatment and competitive landscape, major trends in healthcare, quality, and understanding of clinical management workflow in that particular oncology indication. This is documented by years of experience in oncology clinical practice or clinical research.

Desired Skills/Qualifications:

  •  Strong leadership, team building and people management/coordination skills
  • Excellent verbal and presentation skills
  • A business mindset
  • History of, and desire for, publications in the area of expertise

The above characteristics differentiate the SME from "Medically Experienced" physicians with prior experience in oncology clinical practice or clinical research in a particular indication/drug class/area of oncology clinical research. Whenever possible, these physicians are assigned as medical monitors; however, may also be developed professionally as SMEs once the desired skills and qualifications are acquired.

The Medical Science Leadership Centers (MSLC) are ready to be “plugged in and play” and complement other enterprise teams/functions to help LabCorp Oncology differentiate and win more business.

The MCLCs will:

  • Collaborate with cross Enterprise teams and functional areas (e.g. OS&P, BD, FRE, Delivery) to assure that relevant medical/scientific input is incorporated into a bespoke end-to-end delivery strategy for Oncology
  • Work with our BD colleagues to identify and actively pursue relevant medical/scientific discussions with sponsors 
  • Provide Oncology specific therapeutic insight and training
  • Work with Biopharma medical leaders to assure services process consistency across the enterprise
  • Provide a mentorship program for other physicians who wish to gain experience as part of their individual professional development

Medical Oncology Therapeutic Experts and Consultants website:

https://drugdevelopment.labcorp.com/industry-solutions/oncology/clinical/clinical-oncology-team.html

Entamons le dialogue

Nous contacter